Protein Dynamics and MIF Functionality: How the Catalytic and CD74
Activation Sites Communicate
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ABSTRACT

METHODS

Macrophage migration inhibitory factor (MIF) is a
pleiotropic protein with catalytic, CD74, CXCR2, CXCR4,
and nuclease activities that contribute to the pathology of
various inflammatory disorders, cardiovascular diseases,
and cancer. The majority of MIF-triggered pathological
conditions are associated with the activation of CD74,
MIF’s cell surface receptor. The mechanistic details of
MIF-induced activation of CD74 were mostly unknown
until recently where it was shown that intramolecular
dynamic signals transmitted from an allosteric center
regulate the CD74 activation site on MIF’s surface. Via
backbone dynamic signals, the same center also controls
the enzymatic pocket of MIF and more specifically the
catalytically active residue Pro1, which serves as the sole
target for the discovery and development of CD74
antagonists. Through these findings, the need to explore
the dynamic communication between the enzymatic and
CD74 activation sites became apparent. By utilizing
molecular dynamics (MD) simulations, nuclear magnetic
resonance (NMR) and circular dichroism (CD)
experiments, we investigated how changes of the Nterminal flexibility influence the surface of MIF. Despite
the limited conformational flexibility of MIF, our findings
support that dynamic signals transmitted from the
enzymatic site reach the surface of MIF, affecting CD74
activation. These data increase our understanding of the
role of protein dynamics in MIF functionality and can be
utilized for the development of MIF therapeutics.

Mutagenesis, Protein Expression, and Purification. WT

BACKGROUND
The MIF-induced activation of CD74 is associated with
upregulation of ERK1/2, NF-κB, PI3K/AKT and AMPK
pathways resulting in cell proliferation, survival, and
inhibition of apoptosis.1 This has made the MIF-CD74 axis
an attractive target for a number of immune-related
disorders. Due to CD74’s intrinsically disordered structure,2
study of the receptor is very challenging. Currently, all the
known CD74 antagonists target the catalytic residue Pro1
within the MIF tautomerase active site.3-5 Although the
mechanism is unclear, antagonists of the MIF-induced
activation of CD74 are thought to work by influencing the
MIF-CD74 interface outside the catalytic site of MIF.3,5
Previous studies have shown that the tautomerase and
CD74 activation sites of MIF were independently
connected with the allosteric residue Tyr99 that modulates
their activities.6,7 However, there have been no studies
exploring the dynamic communication between the two
sites or the role of MIF N-terminus in activation of CD74.

MIF and MIF variants were grown at 37°C to an OD600 of 0.6-0.8
and induced with 1mM IPTG for 4 hours at 37°C. MIF proteins
were purified using ion exchange (Q- Sepharose) and size
exclusion (16/60 Superdex 75) chromatography. Protein
concentration was determined with the Pierce™ BCA protein
assay kit (Thermo Fisher Scientific).
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Spectroscopy.

Secondary
structure scans and thermal denaturation experiments were
carried out in a 1 mm quartz cuvette using a JASCO J-810
spectropolarimeter.

MD Simulations. 200ns molecular dynamics simulations were

performed for WTMIF and MIF variants. The systems’ waters,
side chains, and then entirety were then minimized (20ps),
heated to 300K (120ps), and equilibrated (1ns). Generalized
cross correlation data for α-carbon atoms and RMSF values
were produced with GROMACS. RMSD data were obtained
using SUPERPOSE and all models were analyzed in PyMOL.

• Probe the potential dynamic pathway that connects the
N-terminus with the MIF surface responsible for
activation of CD74.
• Analyze the factors that distinguish MIF variants serving
as CD74 antagonists or agonists.

Figure 2. 1H-15N HSQC NMR spectral overlays of P1G (blue), P1M
(yellow), ∆P1 (red), and M2A (purple) MIF with WT MIF (black).

Figure 5. MIF variants serving as CD74 antagonists or agonist. Nterminus changes result in negative or positive cooperativity, as
determined by MD simulations. In vivo CD74 activation assays, correlate
negative and positive cooperativity with antagonist and agonistic effect,
respectively.

NMR experiments. 1H-15N TROSY HSQCs and spin relaxation

experiments were carried out on a Bruker Avance NEO 600 MHz
spectrometer at 30°C. The 1H and 15N carrier frequencies
were set to water resonance and 120 ppm, respectively. All NMR
spectra were processed with NMRpipe and analyzed in Sparky.
Relaxation experiments were carried out in a temperaturecompensated interleaved manner, processed with in-house
scripts, and analyzed in GraphPad Prism 8.0 (GraphPad
Software).

RESULTS

Figure 3. Protein folding and stability analysis for WT MIF and the MIF
variants. A. Folding profiles were monitored between 260nm and 195nm, at
25°C. B. Thermal stability curves for WT MIF and MIF variants were
determined at 218nm. C. CD spectroscopy shows a difference between the
WT and ∆P1 that can be attributed to the loss of the rigid Pro1. Due to the
increased flexibility of the N-terminus, Met2 can no longer participate in the βsheet.

Figure 6. Relaxation parameters of MIF variants vs. WT. A. R1R2
relaxation rates compare dynamics of WT MIF and the MIF variants.
P1M and P1G both see broadening effects; this suggests that the
disturbance of Pro1 results in dynamic changes to neighboring residues.
B. This is also present in the 1H-[15N] NOE data. Both pieces of data
support, that displacing Pro1 results in dynamic changes in residues 2836, 44-49, and 60-68. Most of these are found on the β2 and β4 strands
which aligns with the data from the MD simulations.

CONCLUSIONS
• The N-terminus regulates β-sheet flexibility and
transmit dynamic signals to the surface through the β2
and β4 strands.
• MIF variants serving as CD74 agonists increase the
overall correlation of key amino acids with the MIF
trimer, while MIF variants serving as CD74 antagonists
decrease it.

Global MIF Dynamics

AIMS
• Determine the role of MIF N-terminus in activation of
CD74.

RESULTS

Local MIF Dynamics

Trimer - RMSF (Å)

Figure 1. The MIF variants used in this study. The structure of
monomeric WT MIF (PDB entry: 3DJH) is shown in black. The β-strands
are labeled and the catalytically active N-terminus amino acid, Pro1, is
shown as sticks. Although the biological assembly of MIF is homotrimeric,
we illustrate only one monomer for simplicity. The N-terminal sites of MIF
variants P1M (yellow), P1G (blue), M2A (purple) and ∆P1 (red) are shown
at the four corners and obtained from the PDB entries 4PKZ, 1P1G,
4XX7, and 4XX8 for P1M, P1G, M2A, and ∆P1, respectively. Notably, the
N-terminus residue of ∆P1, Met2, adopts two conformations.

Amino Acid 1 - RMSF (Å)

Amino Acid 2 - RMSF (Å)

WTMIF

0.604 ± 0.16

WTMIF

0.690 ± 0.046

0.541 ± 0.014

P1M

0.598 ± 0.18

P1M

0.632 ± 0.018

0.534 ± 0.010

P1G

0.593 ± 0.16

P1G

0.848 ± 0.078

0.560 ± 0.043

(+22.9 % vs WTMIF)
DP1

0.600 ± 0.16

DP1

-

0.619 ± 0.085
(+14.4 % vs WTMIF)

M2A

0.609 ± 0.17

M2A

0.713 ± 0.044

0.536 ± 0.036

Figure 4. Global and local fluctuations of MIF variants as determined by
200ns MD simulations.
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